Trusted, patient-focused nephrology clinical trials designed to improve outcomes, expand access, and support innovation across Florida and beyond.
NEPHROLOGY CLINICAL TRIALS
Why Our Nephrology Clinical Trials Matter?
Strategically built to connect diverse patient populations, our nephrology clinical trials are supported by AI-driven systems and strong patient engagement to accelerate progress in kidney research. We ensure precise pre-screening and expert-led care, supported by a robust database of over 800,000 EMR records.
End Stage Kidney Disease Clinical Trials
A Phase I/IIa clinical trial evaluating an investigational IV treatment for adults with end-stage kidney disease on hemodialysis. This study focuses on safety and how the body processes the treatment, with expert monitoring throughout. Participants receive no-cost care, including infusions, lab work, and ongoing support during the study period.
The study includes screening, dosing, and follow-up visits over several months, designed to fit alongside your current care routine. By joining, you not only access dedicated medical attention but also help advance future treatment options for kidney disease.
Age
Phase I: 18–55 Years / Phase IIa: 18+ Years
Gender
Male & Female
Condition
End-Stage Kidney Disease (ESKD) on Hemodialysis
Location
Florida
South Carolina
APOL1-Mediated Proteinuric Kidney Disease
A clinical research study evaluating investigational oral treatments for children and adults with APOL1-mediated proteinuric kidney disease. These studies focus on safety, tolerability, and how treatments may help reduce protein in urine while supporting long-term kidney health. Participants receive no-cost medical care, lab work, and ongoing monitoring throughout the study.
Study participation may include screening, taking oral medication, regular health assessments, and follow-up visits, all designed to fit your routine. By joining, you gain access to expert care while contributing to research that may improve future treatment options.
Focal Segmental Glomerulosclerosis Clinical Trials
Clinical research studies evaluating investigational treatments for adolescents and adults living with FSGS. These Focal Segmental Glomerulosclerosis clinical trials focus on understanding how new therapies may impact kidney function, while ensuring safety through consistent monitoring and expert care. Participants receive no-cost medical care, lab work, and ongoing support throughout the study.
Participation includes screening, scheduled study visits, treatment phases, and follow-up care, all designed to provide a structured and supportive experience. By joining an FSGS Research Study, you contribute to advancing knowledge and potential future treatment options for this rare kidney condition.
Age
12–17 Years (adolescents, where approved) and 18 Years and older
Gender
Male & Female
Condition
Focal Segmental Glomerulosclerosis (FSGS)
Location
Florida
South Carolina
Antineutrophil Cytoplasmic Antibody Clinical Trials
A Phase 4 clinical research study evaluating an investigational oral treatment for adults with ANCA-associated vasculitis. These Antineutrophil Cytoplasmic Antibody clinical trials focus on long-term safety, disease control, and relapse prevention while participants continue standard care. All study-related medical care, lab work, and monitoring are provided at no cost.
Participation includes screening, random assignment to treatment, daily oral medication, and regular clinic visits over time, followed by continued monitoring. This structured approach ensures ongoing support while contributing to research that may improve future care for ANCA-associated vasculitis.
Age
18 Years to 100 Years
Gender
Male & Female
Condition
Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Location
Florida
South Carolina
Primary Membranous Nephropathy Clinical Trials
Clinical research studies evaluating investigational treatments for adults living with primary membranous nephropathy. These primary membranous nephropathy clinical trials focus on understanding immune-driven disease activity, safety, and how new therapies may improve kidney outcomes. Participants receive no-cost medical care, lab work, and ongoing monitoring throughout the study.
Participation includes screening, scheduled treatments such as IV infusions or injections, and regular follow-up visits over time. This structured approach ensures consistent care while contributing to research that may improve future treatment options for PMN.
Age
18 Years to 75 Years
Gender
Male & Female
Condition
Primary Membranous Nephropathy (PMN)
Location
Florida
South Carolina
Commonly Asked Questions
What are nephrology clinical trials?
Nephrology clinical trials are research studies focused on evaluating new treatments, therapies, or interventions for kidney-related conditions.
Are nephrology clinical trials safe?
Yes, all our nephrology clinical trials in Florida follow strict regulatory guidelines, ensuring patient safety, ethical standards, and expert medical oversight.
Who can participate in a nephrology clinical trial?
Eligibility depends on your condition, age, and medical history. Our team will guide you through a simple screening process to determine qualification.
Do I receive medical care during the study?
Yes, participants receive ongoing monitoring and care from experienced, board-certified investigators throughout the trial.
